Search

Your search keyword '"Lupus -- Care and treatment -- Research"' showing total 2 results
Start Over Descriptor "Lupus -- Care and treatment -- Research" Publisher right vision media
2 results on '"Lupus -- Care and treatment -- Research"'

1. Galapagos announces start of Phase 2 study with selective TYK2 inhibitor, GLPG3667, in patients with active systemic lupus erythematosus

Subjects
Galapagos N.V. -- Product development, Medical research, Medicine, Experimental, Lupus -- Care and treatment -- Research, Systemic lupus erythematosus -- Research -- Care and treatment, Clinical trials -- Research, Pharmaceutical industry -- Product development, Business, international
Abstract

Mechelen : Galapagos Genomics N (GLPGF.PK) has issued the following press release: Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the first patient was randomized in GALACELA, a Phase [...]

Published
2023

2. Phase 2 Study of Upadacitinib (RINVOQ(r)) Alone or as a Combination Therapy Meets Primary and Key Secondary Endpoints in Patients with Systemic Lupus Erythematosus

Subjects
Medical research, Medicine, Experimental, Lupus -- Care and treatment -- Research, Systemic lupus erythematosus -- Research -- Care and treatment, General interest, News, opinion and commentary, Rinvoq (Medication) -- Research
Abstract

NORTH CHICAGO: Auto Copied has issued the following news release: AbbVie (NYSE: ABBV) today announced the results of the Phase 2 SLEek study evaluating upadacitinib (RINVOQ(r) 30 mg) alone and [...]

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results